ArticleCancers2023

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation.

Davidson Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.